Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04131647 · ClinicalTrials.gov registry record · NA
Promotion of Weight Management
A NA study of Overweight, sponsored by VA Office of Research and Development.
- Active
- Registry status
- NA
- Development phase
- 175
- Enrollment target
- 2
- Study locations
NCT04131647: Active NA study of Overweight, sponsored by VA Office of Research and Development.
NCT04131647 is a NA study of Overweight that is active but no longer recruiting, run by VA Office of Research and Development. The registered enrollment target is 175 participants, below the 1,322-participant average among 197 other Overweight trials with a reported enrollment target (87% lower). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04131647, a NA study of Overweight, is active but no longer recruiting, sponsored by VA Office of Research and Development.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 175 participants
- Enrollment target
- 2
- Study locations
Study Summary
The identification of intermittent fasting as an alternative method to traditional weight maintenance protocols could have a significant impact on preventing body weight regain common after successful weight loss, and potentially lead to a reduction in pharmaceutical and clinical costs related to the care of overweight and obese adults.
Primary Outcome
weight in kg
Conditions Studied
Interventions
- OTHER Weight Maintenance
- OTHER Weight Maintenance + Intermittent Fasting
Study Locations (2)
Maryland
- Baltimore VA Medical Center VA Maryland Health Care System, Baltimore, MD - Baltimore
Texas
- South Texas Health Care System, San Antonio, TX - San Antonio
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 175 participants |
| Start Date | 2021-03-01 |
| Est. Completion | 2026-10-01 |
| Phase | NA |
What the registry record for NCT04131647 still lists
NCT04131647 is an interventional study that assigns participants to a tested intervention. The registered 175 participants enrollment target is mid-sized for trials with a published cap, below the 1,322-participant average among 197 other Overweight trials with a reported enrollment target (87% lower).
The record links to 1 condition, with Overweight appearing as the primary indexed condition, and to 2 interventions - of which Weight Maintenance is the first listed.
NCT04131647 reports a single indexed study location in Maryland, Texas.
Frequently Asked Questions
What is clinical trial NCT04131647 about?
NCT04131647 is a clinical study titled "Promotion of Weight Management". The identification of intermittent fasting as an alternative method to traditional weight maintenance protocols could have a significant impact on preventing body weight regain common after successful weight loss, and potentially lead to a reduction in pharmaceutical and clinical costs related to th...
What is the current status of trial NCT04131647?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 175 participants. The study started on 2021-03-01. Estimated completion is 2026-10-01.
What conditions does trial NCT04131647 study?
This clinical trial studies the following conditions: Overweight.
What interventions are being tested in trial NCT04131647?
The interventions under investigation include: Weight Maintenance (OTHER), Weight Maintenance + Intermittent Fasting (OTHER).
Who is sponsoring clinical trial NCT04131647?
This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04131647 being conducted?
This trial has 2 study locations across Maryland, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Overweight
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04131647's enrollment target sits among peer trials
175 87th of 197 higher than 111 of 197 other Overweight trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Overweight trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
HealthyTogether: RCT of a Dyadic Weight Management Intervention
RECRUITING · NA
-
Eliminating Severe Maternal Morbidity With Heart Health Doulas Trial
RECRUITING · NA
-
Time Restricted Feeding, Muscle, and Metabolism
RECRUITING · NA
-
Diet Order Effects of Low Fat vs. Low Carb Diets on Body Fat Change
RECRUITING · NA
-
Optimization of Chrononutrition to Reduce the Risk of Disease in Shift Workers
RECRUITING · NA
-
The Influence of Honey-flavored Yogurt on Low-grade Inflammation and Gut Health in Middle to Older Aged Women.
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04722341 · 175 participants · NA
Time-Restricted Eating and Cancer: Clinical Outcomes, Mechanisms, and Moderators
- NCT05094037 · 175 participants · NA
Orthotic Treatment of Diabetic Foot Ulcers
- NCT05165745 · 175 participants · NA
Stick2PrEP Cisgender Women and Trans Individuals
- NCT05312255 · 175 participants · NA
Non-chemotherapeutic Interventions for the Improvement of Quality of Life and Immune Function in Patients With Multiple Myeloma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI